Medical device firm The Orthopaedic Implant Company (OIC) has introduced Intramedullary Tibial Nailing system to stabilize fractures of the tibia.
The system has proximal and distal screw holes that can accommodate varying fracture patterns with proximally-placed slotted holes that give option for dynamisation.
The nail comes in diameters of 9mm through 11.5mm and lengths of 280mm to 420mm and features 5.0mm diameter cross-lock screws for optimal implant fixation.
OIC’s Tibial Nail is part of IM Nail system and uses the same instrumentation like all of IM nails. The company claims that the new system can decrease inventory burdens and costs and at the same time increase intra-operative efficiencies.
It is the third nail that has been released by the company in the last twelve months to address long bone fractures.
OIC product design and customer experience vice president Todd Martens said: "We are very proud to offer the addition of the OIC Tibial Nail to our high value implant portfolio.
"We've designed the entire IM Nail System to meet the demands of value based healthcare; a rapidly growing trend."
Recently, an independent study published in the Journal of Orthpaedic Trauma found that the company’s implants were clinically equivalent to others while offering cost benefits.
The study was conducted on 828 patients and the cost savings achieved by the hospital on all the patients collectively was about $450,000.
In August last year, the company had launched an Antegrade/Retrograde Intramedullary Femur Nail (ARFN) system, designed to treat femoral midshaft and distal fractures, while offering both retrograde and antegrade approaches in one implant design.